Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Purity | ≥98% |
---|---|
Formula | C18H18O4 |
Formula Wt. | 298.33 |
IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
Appearance | White Crystal Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Niacin derivative.
NSAID; COX-1/2 inhibitor.
JAK2 inhibitor.
Antioxidant, vitamin E derivative found in vege...
Macrolide; vacuolar H+-ATPase inhibitor.
Pyrimidine nucleoside (cytidine) analog; DNA ch...
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
Pt-based DNA cross-linker.
Impurity of everolimus
Phytoestrogen found in various plant sources; E...
p38 MAPK inhibitor.
LRRK2 inhibitor.
PLK4 inhibitor.
Endogenous tripeptide, involved in HPA signalin...
Endogenous component of sphingolipids; PKC inhi...
Adenosine A2A agonist.
Fluorinated aminopropyl carbazole, neuroprotect...
Prenylated flavonoid found in Humulus lupulus.<...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Pyridopyrimidinone; PI3K and mTOR inhibitor.